| 000 | 03435nam a22004095i 4500 | ||
|---|---|---|---|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 999 |
_c99933 _d99933 _x1 |
||
| 001 | 99933 | ||
| 003 | DE-He213 | ||
| 005 | 20230110040157.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180502s2018 gw | s |||| 0|eng d | ||
| 020 | _a9783319658773 | ||
| 024 | 7 |
_a10.1007/978-3-319-65877-3 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 041 | 0 | _aeng | |
| 050 | 4 |
_aRE661.M3 _b2018 EB |
|
| 245 | 0 | 0 |
_aManagement of Macular Hemorrhage _cedited by Lars-Olof Hattenbach |
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2018 |
|
| 300 |
_a1 recurso en línea (IX, 96 páginas) _b81 ilustraciones, 75 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _aTypes of Macular Hemorrhages and Clinical Appearance -- Macular Hemorrhage: Natural Course and Risk Factors -- Classification of Subretinal Hemorrhage -- The Pathophysiology of Subretinal Hemorrhage -- Anti-VEGF and Fibrinolytic Agents for the Management of Subretinal Hemorrhage -- Minimally Invasive Surgical Approaches to the Management of Macular Hemorrhages -- Surgical Treatment of Massive Subretinal Hemorrhage -- Macular Translocation in Submacular Hemorrhage Secondary to Age-Related Macular Degeneration -- Retinal Pigment Epithelium and Choroid Translocation in Massive Submacular Hemorrhage.-Surgical and Nonsurgical Treatment of Pre-Retinal Hemorrhages -- Management of Trauma Associated Macular Hemorrhages. | |
| 520 | 3 | _aSub- or preretinal hemorrhage involving the macula is a typical complication in a variety of ocular diseases, including age-related macular degeneration, arterial macroaneurysm, Valsalva retinopathy, and trauma. However, there is currently no consensus regarding the ideal treatment for macular hemorrhage. The purpose of this book on macular hemorrhage is twofold: it aims both to impart valuable information on pathophysiology, risk factors, diagnostic aspects, and prognostic criteria under different conditions and to provide a systematic overview of therapeutic approaches that cover the most important situations a vitreoretinal surgeon might encounter when treating patients with this disorder. Case presentations, clinical photographs, and an extensive review of the literature supplement the important information on clinical decision making, surgical techniques, and typical pitfalls and invite the reader to explore the advantages and disadvantages of various approaches to the management of macular hemorrhage. | |
| 988 | _aSpringer_Medicine_2018 | ||
| 650 | 7 |
_2embne _9672818 _aMácula lútea _xEnfermedades |
|
| 650 | 7 |
_2embne _aDegeneración macular _9670079 |
|
| 700 | 1 |
_aHattenbach, Lars-Olof. _eeditor literario _0http://id.loc.gov/authorities/names/n2013180231 _0http://viaf.org/viaf/295316241 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783319658759 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783319658766 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-65877-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE _n0 |
||
| 998 |
_b03/2020 _dz _eb _zSI |
||